Spatiotemporal Targeting Randle Cycle and Immune Checkpoint for Potent Antitumor Therapy
Advanced Science · 2026
DOI: 10.1002/advs.76109 ↗At a glance
Journal article in Advanced Science, 2026. Written by Yuan Gao and 11 co-authors. Institution: Central Laboratory, NMPA Key Laboratory For Dental Materials, National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, …. Major MEDLINE topics: Tumor Microenvironment, Immunotherapy, Immune Checkpoint Inhibitors, Neoplasms. 64 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Key R&D Program of China, Beijing Natural Science Foundation, Fundamental Research Funds for the Central Universities.
Abstract (original language)
Tumor metabolic reprogramming plays a crucial role in cancer progression and therapeutic resistance. The competitive and compensatory relationship between glucose and lipid metabolism—known as the Randle cycle—poses a major challenge to single‐pathway metabolic inhibition strategies. In this study, we developed a glucose oxidase‐based nanogel (GOX‐NG) system using catechol‐functionalized alginate, which exhibits enhanced tumor penetration, prolonged retention, and sustained glucose depletion in the tumor microenvironment. When combined with etomoxir (ETX), a fatty acid oxidation (FAO) inhibitor, this system effectively implements dual metabolic suppression, thereby enhancing reactive oxygen species (ROS)‐induced immunogenic cell death and reprogramming the tumor immune microenvironment. Further combination with the immune checkpoint inhibitor αPD‐1 amplified antitumor immune responses, achieving complete tumor regression in 60% of animals and full survival in 100% of tumor‐bearing mice. This strategy demonstrates significant potential in the treatment of metastatic tumors through a synergistic starvation–oxidation–immunotherapy loop and paves the way for applying intratumorally‐retaining nanogels to a broad spectrum of therapeutic proteins targeting metabolic pathways.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Central Laboratory, NMPA Key Laboratory For Dental Materials, National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing Laboratory of Biomedical Materials, Beijing Key Laboratory of…
- Institute of Advanced Clinical Medicine, Peking University, Beijing, P. R. China.
- Department of Nanomedicine, Translational Medicine Research Center, & Shanghai Key Laboratory of Nautical Medicine and Translation of Drugs and Medical Devices, Naval Medical University, Shanghai, P. R. China.
- First Clinical Division, Peking University School and Hospital of Stomatology, Beijing, P. R. China.
- Department of Geriatric Dentistry, Peking University School and Hospital of Stomatology, Beijing, P. R. China.
ORCID profiles: Yuan Gao, Xuliang Deng
Funding
- National Key R&D Program of China
- Beijing Natural Science Foundation
- Fundamental Research Funds for the Central Universities
- NSFC/China
- Natural Science Foundation of Beijing Municipality
Cite
APA
Gao, Y., Gong, Z., Fu, Y., Zheng, J., Sang, X., Chen, B., Su, Q., Gao, W., Duan, F., Wei, J., Deng, X., & Liu, X. (2026). Spatiotemporal Targeting Randle Cycle and Immune Checkpoint for Potent Antitumor Therapy. Advanced Science. https://doi.org/10.1002/advs.76109
Vancouver
Gao Y, Gong Z, Fu Y, Zheng J, Sang X, Chen B, et al. Spatiotemporal Targeting Randle Cycle and Immune Checkpoint for Potent Antitumor Therapy. Advanced Science. 2026. doi:10.1002/advs.76109
BibTeX
@article{Gao2026,
author = {Gao, Yuan and Gong, Zijian and Fu, Yixuan and Zheng, Jianan and Sang, Xiao and Chen, Binglin and Su, Qinzhi and Gao, Weiping and Duan, Fei and Wei, Jinqi and Deng, Xuliang and Liu, Xinyu},
title = {Spatiotemporal Targeting Randle Cycle and Immune Checkpoint for Potent Antitumor Therapy},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.76109}
}
EUVIMED